ALLIANCEBERNSTEIN L.P. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$18,000
-50.0%
16,200
+0.6%
0.00%
Q4 2021$36,000
-34.5%
16,1000.0%0.00%
Q3 2021$55,000
+14.6%
16,1000.0%0.00%
Q2 2021$48,000
-86.5%
16,100
-85.4%
0.00%
Q1 2017$355,000
+136.7%
110,000
-1.2%
0.00%
Q4 2016$150,000
-14.3%
111,300
-0.8%
0.00%
Q3 2016$175,000
+17.4%
112,2100.0%0.00%
Q2 2016$149,000
-59.2%
112,210
+62.1%
0.00%
Q1 2016$365,000
-32.8%
69,2100.0%0.00%
Q4 2015$543,000
-19.0%
69,210
-12.7%
0.00%
-100.0%
Q3 2015$670,000
-57.6%
79,310
-45.0%
0.00%0.0%
Q2 2015$1,580,000
+42.3%
144,330
+81.8%
0.00%0.0%
Q1 2015$1,110,000
-17.2%
79,4000.0%0.00%0.0%
Q4 2014$1,341,000
+25.8%
79,4000.0%0.00%0.0%
Q3 2014$1,066,000
+1.0%
79,400
-4.1%
0.00%0.0%
Q2 2014$1,055,000
+7.2%
82,8000.0%0.00%0.0%
Q1 2014$984,000
-18.9%
82,800
-5.8%
0.00%0.0%
Q4 2013$1,214,000
-27.3%
87,900
-8.1%
0.00%
-50.0%
Q3 2013$1,669,000
-7.3%
95,662
-13.6%
0.00%0.0%
Q2 2013$1,800,000110,7510.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,354,963$38,132,0001.80%
Orbimed Advisors 4,520,800$73,201,0001.55%
QVT Financial LP 1,326,610$21,480,0001.44%
BB BIOTECH AG 1,089,828$17,646,0001.27%
Meditor Group Ltd 250,000$4,048,0000.55%
Perimeter Capital Partners, LLC 159,915$2,589,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 156,808$2,539,0000.43%
Broadfin Capital, LLC 117,172$1,897,0000.37%
OXFORD ASSET MANAGEMENT LLP 811,331$13,184,0000.36%
Baker Brothers Advisors 1,016,433$16,458,0000.33%
View complete list of INFINITY PHARMACEUTICALS INC shareholders